Arm Holdings
US.ARM
252.09
+9.50
+3.92%
Arm Holdings
252.09
+9.50
+3.92%
Collector offline (last heartbeat: 19108s ago)
· 2026-09-04 20:02
Pre-market
248.47
+2.42%
After-hours
252.42
+0.13%
Overnight
246.92
+1.78%
Revenue annual, last 8 years
Latest year +22.79% YoY
Margins
- Gross margin
- 97.54%
- Operating margin
- 18.46%
- Net margin
- 18.37%
Key ratios & quality
- PEG ratio
- 12.90
- Altman Z-Score
- 68.74
PEG uses trailing P/E against the 3-year net income growth rate (19.93%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 68.74, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Income statement
| Line item | 2014 | 2015 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.24B | 1.43B | 2.03B | 2.70B | 2.68B | 3.23B | 4.01B | 4.92B |
| Gross profit | 1.18B | 1.38B | 1.88B | 2.57B | 2.57B | 3.08B | 3.89B | 4.80B |
| Selling & admin expenses | 348.96M | 362.82M | 826.00M | 897.00M | 762.00M | 983.00M | 984.00M | 1.12B |
| Research & development | 348.96M | 411.86M | 814.00M | 995.00M | 1.13B | 1.98B | 2.07B | 2.78B |
| Operating profit | 480.95M | 601.64M | 242.00M | 680.00M | 678.00M | 117.00M | 831.00M | 908.00M |
| Pretax profit | 492.62M | 614.53M | 697.00M | 786.00M | 671.00M | 212.00M | 720.00M | 1.16B |
| Tax | 95.10M | 111.26M | 153.00M | 110.00M | 147.00M | -94.00M | -72.00M | 253.00M |
| Net profit | 397.52M | 503.27M | 388.00M | 549.00M | 524.00M | 306.00M | 792.00M | 904.00M |
| Basic EPS | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 1 |
| Diluted EPS | 0.28 | 0.35 | 0.38 | 0.54 | 0.51 | 0.29 | 0.75 | 0.85 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 1.24B | 1.05B | 1.14B | 1.24B | 1.49B | 1.29B |
| Gross profit | 1.21B | 1.02B | 1.11B | 1.21B | 1.46B | 1.25B |
| Selling & admin expenses | 257.00M | 259.00M | 252.00M | 284.00M | 320.00M | 317.00M |
| Research & development | 546.00M | 650.00M | 691.00M | 737.00M | 698.00M | 838.00M |
| Operating profit | 410.00M | 114.00M | 163.00M | 191.00M | 440.00M | 98.00M |
| Pretax profit | 144.00M | 146.00M | 302.00M | 228.00M | 481.00M | 253.00M |
| Tax | -66.00M | 16.00M | 64.00M | 5.00M | 168.00M | -17.00M |
| Net profit | 210.00M | 130.00M | 238.00M | 223.00M | 313.00M | 270.00M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.20 | 0.12 | 0.22 | 0.21 | 0.29 | 0.25 |
Balance sheet
| Line item | 2014 | 2015 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | -- | -- | -- | 3.09B | 3.54B | 4.20B | 4.83B | 6.24B |
| Cash & ST investments | -- | -- | -- | 1.64B | 2.22B | 2.92B | 2.83B | 3.60B |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | -- | -- | -- | 6.51B | 6.87B | 7.93B | 8.93B | 10.70B |
| Total current liabilities | -- | -- | -- | 1.40B | 1.36B | 1.51B | 929.00M | 1.04B |
| Short-term debt | -- | -- | -- | 31.00M | 28.00M | 32.00M | 40.00M | 64.00M |
| Long-term debt | -- | -- | -- | -- | -- | -- | -- | -- |
| Total liabilities | -- | -- | -- | 2,962,000,000.00 | 2,815,000,000.00 | 2,632,000,000.00 | 2,093,000,000.00 | 2,417,000,000.00 |
| Total equity | -- | -- | -- | 3.55B | 4.05B | 5.30B | 6.84B | 8.29B |
| Retained earnings | -- | -- | -- | 1.93B | 2.46B | 2.75B | 3.54B | 4.45B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 4.83B | 5.17B | 5.37B | 5.74B | 6.24B | 6.34B |
| Cash & ST investments | 2.83B | 2.91B | 3.26B | 3.54B | 3.60B | 3.89B |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 8.93B | 9.40B | 9.71B | 10.18B | 10.70B | 11.20B |
| Total current liabilities | 929.00M | 1.04B | 960.00M | 1.06B | 1.04B | 1.21B |
| Short-term debt | 40.00M | 57.00M | 37.00M | 64.00M | 64.00M | 41.00M |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 2,093,000,000.00 | 2,388,000,000.00 | 2,303,000,000.00 | 2,378,000,000.00 | 2,417,000,000.00 | 2,566,000,000.00 |
| Total equity | 6.84B | 7.01B | 7.41B | 7.80B | 8.29B | 8.63B |
| Retained earnings | 3.54B | 3.67B | 3.91B | 4.13B | 4.45B | 4.72B |
Cash flow
| Line item | 2014 | 2015 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -- | -- | 1.23B | 458.00M | 739.00M | 1.09B | 397.00M | 1.52B |
| Depreciation & amortization | -- | -- | 201.00M | 185.00M | 170.00M | 162.00M | 183.00M | 249.00M |
| Free cash flow | -- | -- | 1.07B | 383.00M | 646.00M | 947.00M | 158.00M | 949.00M |
| Dividends paid | -- | -- | -750.00M | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- | -- | -- |
| Ending cash balance | -- | -- | 1.21B | 1.00B | 1.55B | 1.92B | 2.09B | 2.75B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 258.00M | 332.00M | 567.00M | 365.00M | 260.00M | 902.00M |
| Depreciation & amortization | 49.00M | 60.00M | 55.00M | 63.00M | 71.00M | 75.00M |
| Free cash flow | 180.00M | 171.00M | 427.00M | 181.00M | 170.00M | 694.00M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 2.09B | 1.96B | 2.52B | 2.81B | 2.75B | 3.06B |
Returns & efficiency
| Line item | 2014 | 2015 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE % | -- | -- | -- | 15.47 | 13.79 | 6.55 | 13.05 | 11.95 |
| ROA % | -- | -- | -- | 8.43 | 7.83 | 4.14 | 9.40 | 9.21 |
| ROIC % | -- | -- | -- | 14.37 | 12.16 | 4.48 | 11.02 | 10.26 |
| 5-year avg ROE % | -- | -- | -- | -- | -- | -- | -- | 12.16 |
| EBIT margin % | -- | -- | 11.94 | 25.16 | 25.31 | 3.62 | 20.74 | 18.46 |
| FCF / sales % | -- | -- | 52.69 | 14.17 | 24.11 | 29.29 | 3.94 | 19.29 |
| Current ratio | -- | -- | -- | 2.22 | 2.60 | 2.79 | 5.20 | 6.00 |
| Quick ratio | -- | -- | -- | 2.10 | 2.47 | 2.76 | 5.08 | 5.83 |
| Debt / assets | -- | -- | -- | 7.36 | 5.46 | 4.27 | 5.21 | 5.52 |
| LT debt / equity | -- | -- | -- | 6.48 | 4.76 | 3.66 | 4.62 | 4.74 |
| Interest coverage | -- | -- | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) % | 17.47 | 15.45 | -- | -- | -- | 16.84 | 14.02 | 22.46 |
| Net income CAGR (3Y) % | 31.50 | 24.68 | -- | -- | -- | -7.61 | 12.99 | 19.93 |
| FCF CAGR (3Y) % | 19.92 | 9.71 | -- | -- | -- | -3.93 | -25.56 | 13.68 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE % | 13.05 | 11.03 | 12.37 | 11.27 | 11.95 | 13.35 |
| ROA % | 9.40 | 8.09 | 9.33 | 8.58 | 9.21 | 10.14 |
| ROIC % | 11.02 | 9.18 | 10.29 | 9.28 | 10.26 | 11.51 |
| 5-year avg ROE % | -- | -- | -- | -- | -- | -- |
| EBIT margin % | 20.74 | 18.51 | 19.54 | 18.80 | 18.46 | 17.30 |
| FCF / sales % | 3.94 | 15.94 | 25.79 | 20.53 | 19.29 | 28.55 |
| Current ratio | 5.20 | 4.99 | 5.59 | 5.43 | 6.00 | 5.25 |
| Quick ratio | 5.08 | 4.88 | 5.23 | 5.25 | 5.83 | 4.88 |
| Debt / assets | 5.21 | 5.65 | 5.54 | 5.91 | 5.52 | 5.38 |
| LT debt / equity | 4.62 | 4.84 | 5.04 | 5.09 | 4.74 | 4.90 |
| Interest coverage | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) % | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) % | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) % | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-09-04 20:02:32
For reference only, not investment advice.